Lifestyle & Healthslider Lilly’s EBGLYSS® (lebrikizumab-Ibkz) single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis by Karine Ayoub March 20, 2025 by Karine Ayoub March 20, 2025 Among EBGLYSS Week 16 responders from the monotherapy trials, 50% achieved highest bar of… 0 FacebookTwitterPinterestEmail